A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors

NCT07263594 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Cancer

Interventions

DRUG: DB-1324

Sponsor

DualityBio Inc.

Collaborators

[object Object]